Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.
Qingqin TanLingjie HeXiaojun MengWei WangHudan PanWeiguo YinTianchuan ZhuXi HuangHong ShanPublished in: Journal of nanobiotechnology (2021)
Collectively, such macrophage biomimetic nanocarriers based drug delivery system showed favorable anti-inflammation and targeted antiviral effects, which may possess a comprehensive therapeutic value in COVID-19 treatment.